Praxis Precision Medicines, Inc. insider Marcio Souza reported a change in beneficial ownership of the company’s common stock on July 8, 2026, involving a transfer of shares to the Souza 2026 Trust. According to the Form 4, the reported transaction was a “bona fide gift” of Praxis common stock. That means the filing describes a transfer without a sale in the market and without a reported purchase or sale price. The explanatory note states that the common stock was gifted to the Souza 2026 Trust, indicating the shares were moved into a trust vehicle rather than sold for cash. The filing text provided does not disclose the number of shares transferred, the transaction code, the post-transaction ownership amount, or whether Souza retains indirect beneficial ownership through the trust. No option exercise, equity vesting event, or open-market purchase or sale is described. The form was signed on Souza’s behalf by Alex Nemiroff as attorney-in-fact. For investors, the key point is that the filing reports an insider ownership restructuring through a gift to a trust, not an apparent market disposition of Praxis Precision Medicines shares.